Opening the Frontier of the T Cell Surface: Schlossman and Goldstein

Monoclonal Abs opened a new frontier in the late 1970s. In an early example of academic/industrial collaboration, Stuart Schlossman at Harvard Medical School and Gideon Goldstein at Ortho Pharmaceuticals emerged as the fastest gunslingers in the Wild West of making mAbs to define T lymphocytes and